HTG Molecular Diagnostics Inc (HTGM) - Medical Equipment - Deals and Alliances Profile
November 2018
63
About the Report
About the Report
Summary
HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services, among others. The company serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.
HTG Molecular Diagnostics Inc (HTGM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
HTG Molecular Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics Inc, Medical Equipment, Deal Details 12
Venture Financing 12
HTG Molecular Diagnostics Raises USD18 Million in Venture Financing 12
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 13
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 14
HTG Molecular Diagnostics Raises USD 7.5 Million In Series E Financing 15
Partnerships 16
HTG Molecular Diagnostics and Firalis Enter into Licensing Agreement 16
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 17
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 18
HTG Molecular Diagnostics to Enter into Agreement with QIAGEN 19
HTG Molecular Diagnostics Enters into Agreement with Merck 20
HTG Molecular Diagnostics Enters into Research Agreement with Instituto Valenciano de Oncologia 21
HTG Molecular Diagnostics Enters into Research Agreement with Centre Leon Berard 22
HTG Molecular Diagnostics Enters into Co-Development Agreement with Qiagen Manchester 23
HTG Molecular Diagnostics Enters into Agreement with Merck 24
HTG Molecular Diagnostics Amends Research Agreement with Bristol-Myers Squibb 25
HTG Molecular Diagnostics Enters into Distribution Agreement with Gamidor Diagnostics 26
HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 27
HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 28
HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 29
HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 30
HTG Molecular Diagnostics Enters Into Development Agreement With OvaGene Oncology 31
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 32
HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John Wayne Cancer Institute 33
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 34
Equity Offering 35
HTG Molecular Diagnostics Raises USD40 Million in Public Offering of Shares 35
HTG Molecular Diagnostics Prices IPO for USD50 Million 37
HTG Molecular Diagnostics Inc-Key Competitors 38
HTG Molecular Diagnostics Inc-Key Employees 39
HTG Molecular Diagnostics Inc-Locations And Subsidiaries 40
Head Office 40
Recent Developments 41
Financial Announcements 41
Aug 07, 2018: HTG Molecular Diagnostics reports second quarter 2018 results 41
May 10, 2018: HTG Molecular Diagnostics Reports First Quarter 2018 Results 42
Mar 22, 2018: HTG Molecular Diagnostics Announces Fourth Quarter And Full Year 2017 Results 43
Jan 04, 2018: HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance 44
Nov 07, 2017: HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings 45
Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results 46
May 15, 2017: HTG Molecular Diagnostics Reports First Quarter 2017 Results 47
Mar 23, 2017: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results 48
Corporate Communications 49
Oct 31, 2018: HTG Molecular appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President 49
Aug 16, 2018: HTG Molecular appoints Michelle R. Griffin to its board of directors 50
Apr 16, 2018: HTG Promotes John Lubniewski to President and Chief Operating Officer 51
Mar 07, 2017: HTG Molecular Diagnostics Appoints New Chair of the Board of Directors 52
Legal and Regulatory 53
Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements 53
Government and Public Interest 54
Jan 10, 2018: University laboratory at Discovery Park is playing key role in early cancer detection research 54
Product News 56
Apr 03, 2018: HTG Announces New Patent for Its Technology Issued in Japan 56
Feb 26, 2018: HTG Announces New Australian Patent for Its Technology 57
Sep 20, 2017: HTG Announces Issuance of Two Method Patents Related to its Technology 58
May 04, 2017: HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017 59
Other Significant Developments 60
Sep 27, 2018: HTG Molecular announces extension to precision diagnostic partnership PDP program three for companion diagnostic submission 60
Aug 09, 2018: HTG Molecular announces amendment to second statement of work with QIAGEN Manchester 61
Feb 27, 2017: HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63
List of Figure
List of Figures
HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
HTG Molecular Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics Raises USD18 Million in Venture Financing 12
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 13
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 14
HTG Molecular Diagnostics Raises USD 7.5 Million In Series E Financing 15
HTG Molecular Diagnostics and Firalis Enter into Licensing Agreement 16
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 17
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 18
HTG Molecular Diagnostics to Enter into Agreement with QIAGEN 19
HTG Molecular Diagnostics Enters into Agreement with Merck 20
HTG Molecular Diagnostics Enters into Research Agreement with Instituto Valenciano de Oncologia 21
HTG Molecular Diagnostics Enters into Research Agreement with Centre Leon Berard 22
HTG Molecular Diagnostics Enters into Co-Development Agreement with Qiagen Manchester 23
HTG Molecular Diagnostics Enters into Agreement with Merck 24
HTG Molecular Diagnostics Amends Research Agreement with Bristol-Myers Squibb 25
HTG Molecular Diagnostics Enters into Distribution Agreement with Gamidor Diagnostics 26
HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 27
HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 28
HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 29
HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 30
HTG Molecular Diagnostics Enters Into Development Agreement With OvaGene Oncology 31
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 32
HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John Wayne Cancer Institute 33
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 34
HTG Molecular Diagnostics Raises USD40 Million in Public Offering of Shares 35
HTG Molecular Diagnostics Prices IPO for USD50 Million 37
HTG Molecular Diagnostics Inc, Key Competitors 38
HTG Molecular Diagnostics Inc, Key Employees 39
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.